Shanghai Fosun Pharmaceutical (600196) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

600196 Shanghai Fosun Pharmaceutical

Watchlist

26.63
-0.11-0.41%

Trading Dec 12 09:52 CST

71.14BMarket Cap33.67P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Fosun Pharma Boosts Equity in Key Funds
TipRanksDec 11 08:09 ET
Express News | Shanghai Fosun Pharma - Ningbo Fuying Will Acquire Equity Interests of RMB200.00 of Fund
ReutersDec 11 07:51 ET
Shanghai Fosun Pharma's New Strategic Agreements With Fosun International
TipRanksDec 11 06:39 ET
FOSUN PHARMA (600196.SH): The controlling subsidiary intends to increase its shareholding in the Fund.
On December 11, Gelonghui reported that FOSUN PHARMA (600196.SH) announced that its holding subsidiary Ningbo Fuying, as an LP of the Nanjing Fund, Dalian Star Future Fund, and Suzhou Angel Fund, signed transfer agreements with FOSUN High Technology regarding the Shareholding of several property interests in these funds. The total consideration for this Shareholding is 140.42 million yuan, which includes: (1) a proposed investment of 90.92 million yuan to acquire another LP share of the Nanjing Fund, for which FOSUN High Technology has already contributed 200 million yuan, accounting for about 25.09% of the total contributed amount of this fund (of which 11 million yuan has been paid in).
Gelonghui FinanceDec 11 03:38 ET
On December 9, Fosun Pharma (02196.HK) spent 4.36 million Hong Kong dollars to repurchase 306,000 shares.
Gelonghui, December 9th丨Fosun Pharma (02196.HK) announced that on December 9, 2024, it spent 4.36 million Hong Kong dollars to repurchase 0.306 million shares at a price of 14.1-14.5 Hong Kong dollars per share.
Gelonghui FinanceDec 9 05:11 ET
Bearish landing? Hong Kong stocks in the pharmaceutical sector collectively strengthen with wuxi apptec rising over 8%.
① How much impact did the biological safety legislation have on domestic pharmaceutical stocks previously? ② How do industry insiders view the subsequent development of the biological legislation?
cls.cnDec 8 21:40 ET

Comments

Spinee

Jun 24 21:45

HSI Opens Up 60 pts; LI AUTO & NIO Advance, as HENLIUS Rockets 21%

Hong Kong stocks opened higher in the morning. $Hang Seng Index (800000.HK)$opened 60 points or 0.3% higher at 18,088. $Hang Seng China Enterprises Index (800100.HK)$ opened 22 points or 0.3% higher at 6,463. $Hang Seng TECH Index (800700.HK)$ opened 11 points or 0.3% higher at 3,689.
$FOSUN PHARMA (02196.HK)$ proposed to privatise $HENLIUS (02696.HK)$ at $24.6 per share. HENLIUS opened rocketing 21.3% at $22.85, while FOSUN PHARMA opened lifting 1.2% at...

Spinee

Apr 25, 2023 11:34

HSI Slides 342 Pts; Techs & Pharmas Gloom

$Hang Seng Index (800000.HK)$ concluded the day at 19,617, down 342 pts or 1.7%. $Hang Seng China Enterprises Index (800100.HK)$ sagged 131 pts or 2% to 6,601. $Hang Seng TECH Index (800700.HK)$ faded 137 pts or 3.5% to 3,824. The turnover aggregated $106.657 billion.
Techs slid as the market continued to be watchful of the Sino-US relations:
$BABA-W (09988.HK)$ dived 3.2% to $84.1.
$TENCENT (00700.HK)$ sank 1.9% to $338.4.
$MEITUAN-W (03690.HK)$ , $XIAOMI-W (01810.HK)$ , ...

Senorita Earnings

Mar 1, 2023 23:54

Columns Expert Meeting Minutes | Seven Development Trends of the China Medical Aesthetics Industry

Core point
1. In the past three years, China's medical beauty industry has undergone earth-shaking changes, and non-surgical products occupy the mainstream
2. The brand is a marketing tool and a social contract for the legal entity to face society. Last year, it began to issue documents on supervising medical aesthetics, focusing on doctors' qualifications, marketing, and the capabilities of three types of ...

Spinee

Dec 14, 2022 00:12

The domestic COVID-19 oral drug Azifodine is planned to be sold online, and $FOSUN PHARMA (02196.HK)$ shares were opened 12% higher to 29 yuan.
$Pfizer (PFE.US)$ $AIM VACCINE (06660.HK)$

Spinee

Dec 6, 2022 21:36

In terms of allocation of Chinese stocks, it is suggested to focus on three main lines:

First, under the optimization of epidemic prevention, the repair market of damaged plates in the early stage, such as biomedical, aviation, wine travel and other plates;
Second, under the demand of stable growth, the industry policy margin is loose, such as the real estate industry chain and the Internet and other industries;
Third, under the theme of security for a long time, energy security, self contro...